Mangoceuticals, Inc.
MGRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,618 | -$5,416 | -$4,839 | -$1,949 |
| Dep. & Amort. | $301 | $836 | $415 | $722 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $51 | $1,045 | $51 |
| Change in WC | -$432 | $81 | $145 | $54 |
| Other Non-Cash | $6,508 | $3,191 | $960 | -$8 |
| Operating Cash Flow | -$1,241 | -$1,256 | -$2,275 | -$1,130 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $600 | $0 | -$38 |
| Stock Issued | $1,622 | $431 | $2,285 | $760 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$588 | $0 | -$802 |
| Other Fin. Act. | $0 | $838 | $0 | $1,202 |
| Financing Cash Flow | $1,622 | $1,281 | $2,285 | $1,122 |
| Forex Effect | -$0 | $0 | $8 | -$8 |
| Net Chg. in Cash | $380 | $25 | $18 | -$15 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $101 | $76 | $59 | $74 |
| End Cash | $481 | $101 | $76 | $59 |
| Free Cash Flow | -$1,241 | -$1,256 | -$2,275 | -$1,130 |